Celebrating its fifth year, the Cannabis Clinical Outcomes Research Conference, or CCORC, brought together more than 120 scientists and medical professionals dedicated to evidence-based cannabis research. The two-day event featured three keynote presentations, six symposia and two poster sessions exploring the latest developments in medical marijuana science.
Hosted by the Consortium for Medical Marijuana Clinical Outcomes Research, the CCORC took place May 29–30 at the UF Academic and Research Center in Orlando.
Rachel Tomko, Ph.D., of the Medical University of South Carolina, delivered the opening keynote address, as she challenged attendees to rethink treatment approaches to cannabis use disorder. Angela Bryan, Ph.D., from the University of Colorado, presented the second keynote on the effects of edible cannabis use on pain, sleep and mood. Sara Jane Ward, Ph.D., from Temple University, offered the final keynote on developing cannabis-based treatments for chemotherapy.
Throughout the event, CCORC reaffirmed its role as a leading forum for advancing the understanding of medical marijuana through science, dialogue and multidisciplinary collaboration. With participation from all 11 member universities in Florida, the consortium strengthened the connections that have driven its success year after year.
“It is exciting to see how the Cannabis Clinical Outcomes Research Conference has maintained strong participation and enthusiasm over five years, helping us advance medical marijuana research,” said Almut Winterstein, R.Ph., Ph.D., co-chair of the conference, distinguished professor of pharmaceutical outcomes and policy in the UF College of Pharmacy and director of the Consortium for Medical Marijuana Clinical Outcomes Research. “The networking and collaborations originating from this conference are impressive. If you review our first year of abstracts compared to today, the quantity and quality of cannabis research in Florida have advanced significantly.”
Winterstein credits Amie Goodin, Ph.D., an assistant professor of pharmaceutical outcomes and policy in the UF College of Pharmacy and chair of the CCORC’s scientific programming committee, for her consistent leadership in enhancing the conference’s program.
More than 50 abstracts were accepted for CCORC, with 11 selected for oral presentations and the remaining as posters. All the abstracts will be published this year in the peer-reviewed journal Medical Cannabis and Cannabinoids.
2025 Event
Cannabis Clinical Outcomes Research Conference
May 29-30 in Orlando
